Ryan Black

Major changes may be coming for the prevention of persistent migraines.

Brivaracetam was approved because it was effective reducing seizure frequency when combined with other agents.

Monoclonal antibody drugs may soon be an effective preventative treatment for chronic migraines.

Erenumab is a monoclonal antibody that inhibits a neuropeptide strongly believed to play a role in the pathology of migraines.

Atrial fibrillation is also more commonly the etiology behind stroke in women than in men.

Amgen is claiming patent infringement against Sanofi and Regeneron based on the biological mechanisms of dupilumab (Dupixent).

Litigation to continue surrounding biological mechanisms of dupilumab (Dupixent).

Fostamatinib treats chronic and persistent immune thrombocytopenia (ITP).

FDA requires additional clinical data to determine the most appropriate doses of Olumiant (baricitinib) for the treatment of rheumatoid arthritis (RA).

Naturally-occurring antibodies that fight HIV open new avenues for research.

Increased presence of myocardial inflammation in patients with rheumatoid arthritis could be treated with non-TNFi biologic disease modifying anti-rheumatic drugs.

There is a need for the surgeons and prescribing rheumatologists to jointly address complications they may cause in RA patients.

The relationship between heart disease and rheumatoid arthritis needs deeper examination.

The amount of information patients receive about disease-modifying anti-rheumatic drugs may overwhelm their memory.

Healthcare support staff and community and social services workers led all occupations in rates of asthma occurrence.

Rheumatic and myocardial inflammation can be treated with disease modifying anti-rheumatic drugs.

Rapid reduction of rheumatoid arthritis symptoms rated as the most important factor in choosing a treatment.

Growing evidence points to the relationship between rheumatoid arthritis and heart problems.

Growing evidence points to the relationship between rheumatoid arthritis and heart problems.

Patients with rheumatoid arthritis want a fast-acting, orally administered treatment for their symptoms.

Anti-tumor necrotic factor drugs could help delay hip deterioration in patients with ankylosing spondylitis.

ACA has record-breaking day as President-elect Donald Trump promises to dismantle controverisal legislation.

Researchers caution against the use of bevacizumab for age-related macular degeneration following cerebrovascular events.

Indomethacin treats various rheumatic conditions, including many forms of tendinitis and arthritis.

Dupilumab shows benefits for the treatment of asthma and atopic dermatitis.

Attacking dormant HIV cells shows promise eradicating disease.